4
Changes in Ownership
Viking Therapeutics, Inc. Filed Acc 0001209191-24-001973
Director sold 30,000 shares at $23.05 ($691,500)
- Director acquired 30,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Rouan Sarah Kathryn · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-01-19 | Exercise or conversion : show line 1 in the form 10b5-1 | +30,000 | $8.32 | $249,600 | 30,000 | D |
| 2024-01-19 | Sale : show line 2 in the form 10b5-1 | −30,000 | $23.05 | $691,500 | 0 | D |
| Open-market sales · 30,000 sh · avg $23.05 · $691,500 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-01-19 | Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy) | −30,000 | 25,000 | D |
Loading xslF345X05/doc4.xml…